This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Down -11.36% in 4 Weeks, Here's Why ABM Industries (ABM) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for ABM Industries (ABM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ABM Industries (ABM) Upgraded to Buy: Here's Why
by Zacks Equity Research
ABM Industries (ABM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Investors Undervaluing ABM Industries (ABM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ABM Industries (ABM) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for ABM Industries (ABM) give a sense of how its business performed in the quarter ended October 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ABM Industries (ABM) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ABM Industries (ABM) delivered earnings and revenue surprises of 4.65% and 4.30%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling ABM Industries (ABM) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for ABM Industries (ABM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.
5 Broker-Loved Stocks to Keep an Eye on as Inflation Woes Stay
by Maharathi Basu
Investors should monitor stocks like American Airlines, Air Canada, ABM, Dollar Tree and AdvanSix for high returns.
ABM Industries Benefits From ELEVATE Plan and High Liquidity
by Zacks Equity Research
RavenVolt buyout, which is a part of ABM's ELEVATE plan, helps the company to expand in new markets.
Is ABM Industries (ABM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Business Services Stocks Lagging Booz Allen Hamilton (BAH) This Year?
by Zacks Equity Research
Here is how Booz Allen Hamilton (BAH) and ABM Industries (ABM) have performed compared to their sector so far this year.
Implied Volatility Surging for ABM Industries (ABM) Stock Options
by Zacks Equity Research
Investors need to pay close attention to ABM Industries (ABM) stock based on the movements in the options market lately.
Should Value Investors Buy ABM Industries (ABM) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Business Services Stocks Lagging Charles River Associates (CRAI) This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and ABM Industries (ABM) have performed compared to their sector so far this year.
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
by Zacks Equity Research
RVTY's continued focus on innovations and a strong product portfolio raise optimism about the stock.
ABM Industries Stock Rises 16% in Six Months: Here's Why
by Zacks Equity Research
ABM's resilient services and sustainability focus have driven strong earnings, boosted by key acquisitions and demand in essential sectors.
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
by Zacks Equity Research
AngioDynamics (ANGO) delivers decent top-line results on a pro-forma basis in first-quarter fiscal 2025, driven by strength in the Med Tech business.
Reasons to Add Avanos Medical Stock in Your Portfolio Now
by Zacks Equity Research
AVNS's strong product line and focus on R&D raise optimism about the stock.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
by Zacks Equity Research
GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.
SYK Stock May Gain From Completion of Vertos Medical Acquisition
by Zacks Equity Research
Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.
Is HealthEquity Stock a Buy Now Amid Strength in HSAs?
by Zacks Equity Research
HQY's strong quarterly results and solid top-line growth raise optimism about the stock.
ITGR Shares Gain on the Divestiture of Its Non-Medical Business Line
by Zacks Equity Research
Integer Holdings announces to divest its Electrochem business to Ultralife for $50 million in cash.
Baxter Shares May Gain on the Launch of Its Latest Vest APX System
by Zacks Equity Research
BAX launches its next-generation airway clearance system, The Vest APX System, for chronic lung conditions.
PDCO Shares Gain Following New Deals to Boost Animal Health Business
by Zacks Equity Research
Patterson Companies announces to invest in two separate businesses to boost its animal health business.
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
by Zacks Equity Research
Strength in NVRO's Senza Platform and business diversification plans raises optimism about the stock.
Accenture's Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
ACN's fourth-quarter fiscal 2024 earnings and revenues increase year over year.